Australia's most trusted
source of pharma news
Friday, 23 January 2026
Friday, 23 January 2026
Subscribe
Login
Trump drug pricing brag turns ugly
Chest-thumping by Donald Trump over US drug prices has turned ugly, with the French Presidency branding his story on how the deal was done as "fake news".
Biggest brand in pharma named
ICYMI: Company takes the crown for the seventh year in a row plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Drs pick favourite obesity drug
Almost nine out of 10 doctors expect to prescribe this drug within six months of launch turning the tables on the usual frontrunner
TODAY
ANZ Country Head unveils new job
After a surprise resignation last year, this leader's next career move has been under wraps... until now. See where she's gone
22 January
Local exec wins Country Leader job
A pharma has appointed a new Country Manager for Australia, while a local biotech brings in a new CEO
21 January
Big names eye Feb PBS listing
Four new drugs could make their first appearance on the scheme along with the first rivals for Bayer and Biogen treatments
21 January
Boss blasts 'luxury yacht bozos'
Company leader drops a clanger and it's not the first time, having previously earned a Rotten Tomato award for his straight talk
21 January
Latest Jobs
Dedicated Principal AgentSales & Key Account AssociateCustomer Service RepresentativeSenior Territory Sales ManagerSenior Quality Assurance AssociateInside Sales SpecialistFinance AdministratorSenior Regulatory Affairs Associate26 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (13)
- Sales & Key Account Associate - Melbourne
- Customer Service Representative - Pemulwuy
- Senior Territory Sales Manager - Melbourne
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- GP Sales Representative - Brisbane
- Pharmaceutical Sales Representative - Gold Coast
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Specialist Account Manager - Sydney
- Customer Service Specialist - Frenchs Forest
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (4)
- Clinical Research, Business Development Manager - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (5)
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Executive Roles (3)
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (12)
- Dedicated Principal Agent - Pemulwuy
- Finance Administrator - Sydney
- GP Rep Bundaberg Contract - Bundaberg
- Warehouse & Logistics Officer - Macquarie Park
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
- Materials Planner - North Ryde
- Senior Recruitment Consultant - Sydney
- Warehouse Coordinator - Alexandria
- HR Analyst (Workday Specialist) - Melbourne
- Senior Recruitment Consultant - Sydney
Op-Ed: Who will win in 2026?
Forces reshaping pharma have re-written the rules for success with bringing a product to market, now just the first step
TODAY
Pharmac racing PBS to list big drug
Provisional agreement reached to fund this anticipated mega blockbuster in NZ in April but will Australia get in first?
TODAY
3.5-year drug shortage finally ends
Bizarre knock-on effect created by a spike in demand for a rival drug triggered an acute shortage and hundreds of complaints to the TGA
22 January
Local giant grows revenue by half
One of Australia's largest home-grown pharmas boosted its last quarter revenue by 46 per cent as it ramps up a global rollout
22 January
Spot-the-difference logo stoush
Despite similarities, IP Australia delegate rules there is no likelihood of confusion between the trademarks of these two treatments
22 January
Cancer vax combo keeps dazzling
Personalised vaccine combo continues to drastically cut the risk of death in resected high-risk melanoma, even after five years
22 January
Pfizer cashes out of ViiV
GSK again has a single partner in the HIV-focused pharma, as it invests billions in an anti-allergy pipeline
21 January
More insulin products to be axed
Both Eli Lilly and Novo Nordisk will discontinue some of their insulin offerings in the second half of 2026 for commercial reasons
21 January
Trump gloats over drug prices
Giving himself a pat on the back for lowering prescription drug prices, the President now wants MFN changes to become law
20 January
Inside Sanofi's new Aussie HQ
Vibrant, contemporary space in the top end of town aligns with the company's transformation into a modern AI-powered pharma
January 20
Aussie drug patents on knife-edge
Many drugs may already be over the patent cliff, leaving pharmas to find their footing in a suddenly changed patent landscape
20 January
Look who's back: execs return
After departing industry, a string of Aussie pharma executives are making a comeback, snapping up senior roles
20 January
Four new treatments hit TGA
The regulator has rolled out a string of orphan drug designation, including one for an old drug which has found a rare disease target
20 January
Pharma's most valuable brand
One pharma is a standout winner valued at almost double that of its nearest rival but for the rest of the field it's a much tighter competition
19 January